120 related articles for article (PubMed ID: 16785127)
1. Central nervous system relapse in acute promyelocytic leukaemia.
Lunghi M; Castagnola C; Calatroni S; Bernasconi P; Lazzarino M
Haematologica; 2006 Jun; 91(6 Suppl):ECR24. PubMed ID: 16785127
[No Abstract] [Full Text] [Related]
2. Reduced intensity conditioning allogeneic bone marrow transplantation following central nervous system (CNS) relapse of acute promyelocytic leukemia: evidence for a graft-versus-leukemia effect in the CNS.
Ostronoff M; Domingues MC; Ostronoff F; Matias C; Florêncio R; Matias K; Souto Maior AP; Sucupira A; Calixto R; Tagliari C
Am J Hematol; 2006 May; 81(5):387-8. PubMed ID: 16628719
[No Abstract] [Full Text] [Related]
3. Central nervous system acute promyelocytic leukaemia: a report of three cases.
Marra R; Stori S; Pagano L; Fioritoni G; Rabitti C; Sica S; Leone G; Torlontano G; Bizzi B
Haematologia (Budap); 1989; 22(3):195-9. PubMed ID: 2583600
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia.
Castagnola C; Elena C; Merli M
Haematologica; 2008 Feb; 93(2):e28. PubMed ID: 18245644
[TBL] [Abstract][Full Text] [Related]
5. Isolated central nervous system recurrence of acute promyelocytic leukemia in children.
Chow J; Feusner J
Pediatr Blood Cancer; 2009 Jan; 52(1):11-3. PubMed ID: 18816805
[TBL] [Abstract][Full Text] [Related]
6. Central nervous system relapse of acute promyelocytic leukemia.
Johnston DL; Mandel K
Pediatr Blood Cancer; 2010 Feb; 54(2):336-7; author reply 338. PubMed ID: 19847884
[No Abstract] [Full Text] [Related]
7. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia.
Jönsson P; Höglund P; Wiebe T; Schrøder H; Seidel H; Skärby T
Anticancer Drugs; 2007 Sep; 18(8):941-8. PubMed ID: 17667600
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system involvement in relapsed acute promyelocytic leukemia.
Kaspers G; Gibson B; Grimwade D; Pession A; Smith O; Testi AM
Pediatr Blood Cancer; 2009 Aug; 53(2):235-6; author reply 237. PubMed ID: 19353622
[No Abstract] [Full Text] [Related]
10. Very high levels of lactate dehydrogenase at diagnosis predict central nervous system relapse in acute promyelocytic leukaemia.
Ohanian M; Rozovski U; Ravandi F; Garcia-Manero G; Jabbour E; Kantarjian HM; Estrov Z
Br J Haematol; 2015 May; 169(4):595-7. PubMed ID: 25413673
[No Abstract] [Full Text] [Related]
11. Central nervous system involvement in acute promyelocytic leukemia. A description of two cases and review of the literature.
Rives S; Camós M; Bosch F; Esteve J; Villamor N; Montserrat E
Haematologica; 1999 May; 84(5):473-4. PubMed ID: 10329934
[No Abstract] [Full Text] [Related]
12. Central nervous system (CNS) infiltration in a case of promyelocytic leukemia.
Molero T; Valencia JM; Gómez-Casares MT
Haematologica; 1997; 82(5):637. PubMed ID: 9407740
[No Abstract] [Full Text] [Related]
13. Extramedullary disease initially without bone marrow involvement in acute promyelocytic leukaemia.
Zuiable A; Aboud H; Nandi A; Powles R; Treleaven J
Clin Lab Haematol; 1989; 11(3):288-9. PubMed ID: 2591162
[No Abstract] [Full Text] [Related]
14. Parotid and central nervous system relapse during complete hematologic remission in acute promyelocytic leukemia.
Mesa JR; Espinosa E; Losada R; Hernandez C; Martinez G; Hernandez P
Haematologica; 1999 Jun; 84(6):565-6. PubMed ID: 10366808
[No Abstract] [Full Text] [Related]
15. Central nervous system relapse of acute promyelocytic leukaemia in a patient with cerebral haemorrhage at diagnosis.
Macheta MP; Shun JK; Yin JA
Br J Haematol; 2001 Sep; 114(4):954-5. PubMed ID: 11564092
[No Abstract] [Full Text] [Related]
16. Interstitial granulomatous dermatitis secondary to acute promyelocytic leukemia.
Swing DC; Sheehan DJ; Sangüeza OP; Woodruff RW
Am J Dermatopathol; 2008 Apr; 30(2):197-9. PubMed ID: 18360133
[No Abstract] [Full Text] [Related]
17. Microgranular relapse of typical hypergranular acute promyelocytic leukemia.
Shivarov V; Nikolova V; Balatzenko G; Guenova M
Leuk Lymphoma; 2006 Dec; 47(12):2661-3. PubMed ID: 17169816
[No Abstract] [Full Text] [Related]
18. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
Reman O; Pigneux A; Huguet F; Vey N; Delannoy A; Fegueux N; de Botton S; Stamatoullas A; Tournilhac O; Buzyn A; Charrin C; Boucheix C; Gabert J; Lhéritier V; Vernant JP; Fière D; Dombret H; Thomas X;
Leuk Res; 2008 Nov; 32(11):1741-50. PubMed ID: 18508120
[TBL] [Abstract][Full Text] [Related]
19. Isolated bowel relapse in acute promyelocytic leukemia: an unusual site of extramedullary recurrence.
Ochs RC; Gormley RH; Luger S; Bagg A
J Clin Oncol; 2010 Oct; 28(29):e550-3. PubMed ID: 20713873
[No Abstract] [Full Text] [Related]
20. [Correlation analysis of central nervous system relapse and cell biological characteristics in acute promyelocytic leukemia].
Yang SW; Ma RJ; Yuan XL; Jiang L; Li YL; Dong XY; Wang Z; Zhang L; Shang BJ; Lei PC; Zhu ZM
Zhonghua Xue Ye Xue Za Zhi; 2021 Jun; 42(6):517-520. PubMed ID: 34384161
[No Abstract] [Full Text] [Related]
[Next] [New Search]
